BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1716 related articles for article (PubMed ID: 21545096)

  • 21. Applications for site-directed molecular imaging agents coupled with drug delivery potential.
    Wang H; Chen X
    Expert Opin Drug Deliv; 2009 Jul; 6(7):745-68. PubMed ID: 19552614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations.
    Lammers T; Subr V; Ulbrich K; Peschke P; Huber PE; Hennink WE; Storm G; Kiessling F
    Nanomedicine (Lond); 2010 Dec; 5(10):1501-23. PubMed ID: 21143030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimuli-responsive polymers and their applications in nanomedicine.
    Cabane E; Zhang X; Langowska K; Palivan CG; Meier W
    Biointerphases; 2012 Dec; 7(1-4):9. PubMed ID: 22589052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Theranostic Path to Personalized Nanomedicine.
    Theek B; Rizzo LY; Ehling J; Kiessling F; Lammers T
    Clin Transl Imaging; 2014 Feb; 2(1):66-76. PubMed ID: 24860796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing switchable nanosystems for medical application.
    Lehner R; Wang X; Wolf M; Hunziker P
    J Control Release; 2012 Jul; 161(2):307-16. PubMed ID: 22580190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging trends of nanomedicine--an overview.
    Sandhiya S; Dkhar SA; Surendiran A
    Fundam Clin Pharmacol; 2009 Jun; 23(3):263-9. PubMed ID: 19527298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology for neurodegenerative disorders.
    Re F; Gregori M; Masserini M
    Nanomedicine; 2012 Sep; 8 Suppl 1():S51-8. PubMed ID: 22640910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel applications of nanotechnology in medicine.
    Surendiran A; Sandhiya S; Pradhan SC; Adithan C
    Indian J Med Res; 2009 Dec; 130(6):689-701. PubMed ID: 20090129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-targeted nanoparticles for cancer therapy.
    Fay F; Scott CJ
    Immunotherapy; 2011 Mar; 3(3):381-94. PubMed ID: 21395380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal nanomedicines: an emerging field.
    Fenske DB; Chonn A; Cullis PR
    Toxicol Pathol; 2008 Jan; 36(1):21-9. PubMed ID: 18337218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicines: addressing the scientific and regulatory gap.
    Tinkle S; McNeil SE; Mühlebach S; Bawa R; Borchard G; Barenholz YC; Tamarkin L; Desai N
    Ann N Y Acad Sci; 2014 Apr; 1313():35-56. PubMed ID: 24673240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 86.